Search - tctmd.com

Displaying 441 - 460 of 661

Sort: Relevancy | Date

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

早期数据显示抗血小板药物 PZ-128 效果可逆、起效快速，颇具前景

Caitlin E. Cox

December 20, 2015

News Daily News

Prometedores Primeros Datos para el Fármaco Antiplaquetario Reversible de Acción Rápida PZ-128

Caitlin E. Cox

December 20, 2015

News Daily News

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Caitlin E. Cox

December 20, 2015

News Daily News

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Michael O'Riordan

December 15, 2015

News Daily News

CvLPRIT Substudy Finds Little Lasting Damage From Non-Infarct Artery PCI

Caitlin E. Cox

December 15, 2015

News Daily News

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Yael L. Maxwell

December 14, 2015

News Daily News

Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows

Todd Neale

December 14, 2015

News Daily News

Meta-Analysis Boosts Case for Increased Use of Radial Access

November 29, 2015

News Industry News

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

November 23, 2015

News Conference News AHA 2015

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

Todd Neale

November 10, 2015

News Industry News

TherOx Receives FDA IDE Approval for Study of Next-Generation Supersaturated Oxygen Therapy for AMI

November 04, 2015

News Daily News

Post-TAVR Myocardial Injury Linked to Mortality

Caitlin E. Cox

November 02, 2015

Presentation

Stem Cell Therapy for Ischemic Cardiomyopathy

Presenter: Muzammil Mushtaq

October 31, 2015

News Conference News TCT 2015

TOTAL: Manual Thrombectomy Does Not Benefit STEMI Patients at 1 Year

Nicole Lou

October 13, 2015

News Conference News TCT 2015

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

October 11, 2015

News Daily News

Sheathless Guide Catheter Safe, Effective in Transradial Primary PCI

Yael L. Maxwell

September 30, 2015

News Daily News

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

L.A. McKeown

September 21, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Conference News ESC 2015

MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI

Yael L. Maxwell

September 02, 2015

Advertisement

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

早期数据显示抗血小板药物 PZ-128 效果可逆、起效快速，颇具前景

Prometedores Primeros Datos para el Fármaco Antiplaquetario Reversible de Acción Rápida PZ-128

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

CvLPRIT Substudy Finds Little Lasting Damage From Non-Infarct Artery PCI

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows

Meta-Analysis Boosts Case for Increased Use of Radial Access

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

TherOx Receives FDA IDE Approval for Study of Next-Generation Supersaturated Oxygen Therapy for AMI

Post-TAVR Myocardial Injury Linked to Mortality

Stem Cell Therapy for Ischemic Cardiomyopathy

TOTAL: Manual Thrombectomy Does Not Benefit STEMI Patients at 1 Year

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

Sheathless Guide Catheter Safe, Effective in Transradial Primary PCI

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content